Table 2 Baseline clinical and related characteristics of patients included in the study
Variable | Number (%) |
|---|---|
Functional status | |
Working | 124 (37.6) |
Ambulatory | 91 (28.6) |
Bedridden | 115 (34.8) |
CPT | |
Received | 211 (64) |
Not received | 119 (36) |
Isoniazid preventive therapy (IPT) | |
Not received IPT | 235 (71.21) |
Received IPT | 95 (28.79) |
Duration of follow-up on ART | |
Follow-up time < 12 months | 222 (67) |
Follow-up time > 12 months | 108 (33) |
WHO clinical stage | |
I | 35 (11) |
II | 69 (21) |
III | 140 (42) |
IV | 86 (26) |
Opportunistic infection | |
Opportunistic infection | 131 (39.70) |
No opportunistic infection | 199 (60.30) |